Curis (CRIS) Profit After Tax (2010 - 2026)
Curis (CRIS) reported Profit After Tax of -$24.2 million for Q1 2026, down 127.96% on a YoY basis from $86.6 million in Q1 2025, and down 225.14% quarter-over-quarter from $19.3 million in Q4 2025.
Curis (CRIS) Profit After Tax (2010 - 2026) Analysis & Trends
Curis has reported Profit After Tax for 17 years, with the latest figure at -$24.2 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 127.96% year-over-year to -$24.2 million; the trailing twelve-month figure through Mar 2026 stood at -$21.2 million (up 49.72% YoY), and the FY2025 full-year result was -$7.6 million, up 82.48% from the prior year.
- Profit After Tax for Q1 2026 stood at -$24.2 million, down from $19.3 million in the prior quarter.
- The five-year high for Profit After Tax was $19.3 million in Q4 2025, with the low at -$24.2 million in Q1 2026.
- Historically, Profit After Tax has averaged -$10.5 million across 5 years, with a median of -$11.7 million in 2023.
- Annual changes were most pronounced in 2025 — Profit After Tax surged 301.06% — and 2026, when it plunged 127.96%.
- Curis' Profit After Tax stood at -$11.3 million in 2022, then declined by 3.38% to -$11.7 million in 2023, then grew by 17.88% to -$9.6 million in 2024, then surged by 301.06% to $19.3 million in 2025, then plunged by 225.14% to -$24.2 million in 2026.
- The last three Profit After Tax figures came in at -$24.2 million (Q1 2026), $19.3 million (Q4 2025), and -$7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Curis | 8.37 Mn | -6.63 Mn | - | -24.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.20 Mn |
| Dec 31, 2025 | 19.34 Mn |
| Sep 30, 2025 | -7.73 Mn |
| Jun 30, 2025 | -8.59 Mn |
| Mar 31, 2025 | -10.62 Mn |
| Dec 31, 2024 | -9.62 Mn |
| Sep 30, 2024 | -10.09 Mn |
| Jun 30, 2024 | -11.80 Mn |
| Mar 31, 2024 | -11.88 Mn |
| Dec 31, 2023 | -11.71 Mn |
| Sep 30, 2023 | -12.18 Mn |
| Jun 30, 2023 | -11.96 Mn |
| Mar 31, 2023 | -11.56 Mn |
| Dec 31, 2022 | -11.33 Mn |
| Sep 30, 2022 | -13.29 Mn |
| Jun 30, 2022 | -15.94 Mn |
| Mar 31, 2022 | -16.11 Mn |
| Dec 31, 2021 | -13.62 Mn |
| Sep 30, 2021 | -11.05 Mn |
| Jun 30, 2021 | -10.84 Mn |